BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2014
View Archived Issues
Scientists identify miR-34a as suppressor of osteoclastogenesis and bone resorption
Read More
Antiviral agent from N & N Scientific receives FDA orphan drug designation
Read More
Bayer HealthCare establishes collaboration with Kyoto University
Read More
Alchemia reports phase III trial results for HA-irinotecan in mCRC
Read More
Pfizer discontinues agreement to develop Remoxy
Read More
Receptos' TOUCHSTONE trial of RPC-1063 for ulcerative colitis meets endpoints
Read More
Vaxart eyes clinical trials of Ebola tablet vaccine
Read More
Compugen releases validation results on new cancer immunotherapy target candidate
Read More
HRA Pharma acquires rights to ovarian cancer immunotherapy from Pantarhei Bioscience
Read More
Genetic risk factors for hepatotoxicity from antituberculosis therapy identified
Read More
Chugai reports pipeline progress of third quarter 2014
Read More
MicroRNAs linked to preneoplastic gastric conditions
Read More
Novel carboxamide derivatives patented for HBV infection
Read More
CSIR patents novel oxindoles for tuberculosis
Read More
Kurume University discloses new cancer antigen peptide vaccines
Read More
Novel compounds disclosed by Roche for schizophrenia and other disorders
Read More
Takeda Pharmaceutical prepares new CH24H inhibitors
Read More
Eisai discloses new PDE9A inhibitors for Alzheimer's disease
Read More
Variants in KCNIP4 associated with ACE inhibitor induced cough
Read More
Glassia named FDA orphan drug for graft-versus-host disease
Read More
Bristol-Myers Squibb enters into agreement to acquire F-star Alpha
Read More
FDA grants fast track designation to ARA-290 for small fiber neuropathy
Read More
Philogen begins phase II study of F8-IL10
Read More
Amgen reviews milestones of third quarter 2014
Read More
Researchers present phase II data for mongersen in active Crohn's disease
Read More
Xencor regains rights to XmAb-5871
Read More
Chembio Diagnostics signs agreements to develop POC diagnostic tests for Ebola, dengue and cancer
Read More
